Diana Vivian, Ph.D.

US Food and Drug Administration

Poster(s):

• (M1430-10-63) Assessing In Vitro Release Testing (IVRT) in Bioequivalence Studies for Complex Products - Considerations for Ophthalmic versus Topical Dermatological Dosage Forms
  Monday, October 23, 2023

  2:30 PM – 3:30 PM ET

• (T1130-03-18) Bioequivalence Deficiencies Observed in Sucralfate Oral Suspension Generic Applications: An In-Depth Analysis of the Deficiencies Identified to Help Improve the Quality of Future Submissions
  Tuesday, October 24, 2023

  11:30 AM – 12:30 PM ET

• (T1330-10-69) Evaluation of Applications for Topical Semisolid Drug Products with In Vitro Permeation Test and In Vivo Bioequivalence Study with Pharmacokinetic Endpoints
  Tuesday, October 24, 2023

  1:30 PM – 2:30 PM ET